The drug-loaded oral thin films market is experiencing strong growth as pharmaceutical companies increasingly focus on innovative drug delivery systems that enhance patient convenience, improve medication adherence, and provide rapid therapeutic effects. Oral thin films have emerged as an effective alternative to conventional tablets and capsules, particularly for pediatric, geriatric, and...

The global GLP-1 Receptor Agonist Market was valued at USD 66.4 billion in 2025 and is projected to grow from USD 82.0 billion in 2026 to USD 185.3 billion by 2033, registering a CAGR of 12.4% from 2026 to 2033. The market is witnessing remarkable growth due to the rising prevalence of type 2 diabetes, obesity, and other metabolic disorders, coupled with increasing clinical acceptance...

North America remains a dominant region in the Oral Proteins and Peptides Market due to its well-established healthcare ecosystem, high adoption of innovative pharmaceutical technologies, and increasing focus on biologics development. The region benefits from strong collaborations between research institutions, biotechnology firms, and pharmaceutical manufacturers, fostering continuous...

The pharmaceutical and nutraceutical industries are witnessing rapid transformation, creating strong demand for advanced drug delivery solutions across global healthcare systems. Among the widely adopted dosage formats, gelatin-based capsules continue to hold a dominant position due to their ease of consumption, faster dissolution properties, and compatibility with a wide range of medicinal...